Clinical Trials Browser

Nasopharyngeal Carcinoma

NCT05893810 2024-02-08

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Phase 3 Unknown

176 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03321539 2023-05-22

Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma

Phase 3 Unknown

216 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05757479 2023-03-07

Steroid-Eluting Stent Implant for the Treatment of Radiation-Related Sinusitis

Phase 3 Unknown

168 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04436965 2023-01-31

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Phase 3 Unknown

266 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03837808 2022-11-07

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Phase 3 Unknown

384 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT05519956 2022-09-19

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Phase 3 Unknown

398 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03366415 2022-03-04

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

Phase 3 Unknown

420 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02512315 2021-08-30

A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

Phase 3 Unknown

192 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04766359 2021-02-23

Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma

Phase 3 Unknown

364 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01817023 2021-01-29

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Phase 3 Unknown

590 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03720340 2020-08-11

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Phase 3 Unknown

300 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04414566 2020-06-04

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

562 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02111460 2020-05-08

Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

126 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03403829 2019-07-08

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

Phase 3 Unknown

360 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02958111 2019-06-12

CAN

Phase 3 Unknown

406 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03601975 2019-02-04

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

336 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02633202 2018-12-13

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Phase 3 Unknown

338 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03656965 2018-09-04

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Phase 3 Unknown

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02434614 2018-05-16

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

440 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01872962 2018-04-24

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

480 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03068936 2017-03-03

IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma

Phase 3 Unknown

716 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03015727 2017-01-10

IRCNPC

Phase 3 Unknown

440 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02944708 2016-10-27

Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

384 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02907710 2016-09-20

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

300 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02786641 2016-06-01

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

235 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02621970 2015-12-04

Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

Phase 3 Unknown

534 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02610010 2015-11-20

Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma

Phase 3 Unknown

462 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02537925 2015-09-02

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

Phase 3 Unknown

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02500940 2015-07-17

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

54 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01915134 2015-01-01

Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

362 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02301208 2014-12-08

NPC-RCT-WCRT

Phase 3 Unknown

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00705627 2014-05-28

A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

400 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01245959 2014-02-13

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

476 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00677118 2013-07-12

Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

506 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01536223 2013-03-05

ESNCCT

Phase 3 Unknown

400 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01479504 2011-11-28

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

2 enrolled

Head & Neck

Nasopharyngeal Carcinoma

Clinical Trials

Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma

Steroid-Eluting Stent Implant for the Treatment of Radiation-Related Sinusitis

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

CAN

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma

IRCNPC

Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

NPC-RCT-WCRT

A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

ESNCCT

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma